Aurobindo Pharma Ltd
NSE:AUROPHARMA

Watchlist Manager
Aurobindo Pharma Ltd Logo
Aurobindo Pharma Ltd
NSE:AUROPHARMA
Watchlist
Price: 1 223.7 INR 0.55% Market Closed
Market Cap: 710.7B INR
Have any thoughts about
Aurobindo Pharma Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

10.8
Current
8.7
Median
13.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
10.8
=
Enterprise Value
675B INR
/
EBITDA
62.3B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
9.8
2-Years Forward
EV/EBITDA
8.6
3-Years Forward
EV/EBITDA
8.3

See Also

Discover More